Pediatric cutaneous leishmaniasis in an endemic region in India

Saurabh Agrawal1, Kanika Khandelwal1, Ram A Bumb1

  • 1Department of Dermatology, Sardar Patel Medical College, Bikaner, Rajasthan, India; Department of Molecular Biology, Indian Council of Medical Research, New Delhi, India; Department of Pathology and Microbiology, Ohio State University, Columbus, Ohio.

Insights

Pediatric cutaneous leishmaniasis (CL) in India

Area of Science:

  • Tropical medicine
  • Dermatology
  • Medical entomology

Background:

  • Cutaneous leishmaniasis (CL) is a significant health concern in endemic regions.
  • Pediatric CL presents unique challenges in diagnosis and management.
  • The Bikaner region of Rajasthan, India, is a known endemic area for CL.

Purpose of the Study:

  • To describe the clinicoepidemiological characteristics of pediatric CL in pre-school children (0-5 years).
  • To identify the causative Leishmania species in the Bikaner region.
  • To evaluate treatment outcomes for pediatric CL.

Main Methods:

  • Retrospective analysis of 151 pediatric CL cases from 2001-2012.
  • Clinical examination, parasitological smears, and histopathology for diagnosis.
  • Polymerase chain reaction (PCR) for species identification.
  • Review of treatment modalities and their effectiveness.

Main Results:

  • 151 pediatric CL cases with 217 lesions were reported.
  • The face was the most commonly affected site, with plaque or papulonodular lesions.
  • Leishmania tropica was identified as the causative species in 13 patients via PCR.
  • Intralesional sodium stibogluconate was well-tolerated; oral rifampicin, dapsone, and RFHT also showed efficacy.

Conclusions:

  • Pediatric CL in the Bikaner region predominantly affects pre-school children, with facial lesions being common.
  • Leishmania tropica is the etiological agent in this endemic area.
  • Various treatment options, including intralesional sodium stibogluconate, oral medications, and RFHT, are effective and well-tolerated in pediatric CL management.